Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.

Autor: Walma, M. S.^1,2 (AUTHOR) m.s.walma@umcutrecht.nl, Rombouts, S. J.^1,2 (AUTHOR), Brada, L. J. H.^1,2 (AUTHOR), Borel Rinkes, I. H.¹ (AUTHOR), Bosscha, K.³ (AUTHOR), Bruijnen, R. C.¹ (AUTHOR), Busch, O. R.² (AUTHOR), Creemers, G. J.⁴ (AUTHOR), Daams, F.² (AUTHOR), van Dam, R. M.⁵ (AUTHOR), van Delden, O. M.² (AUTHOR), Festen, S.⁶ (AUTHOR), Ghorbani, P.⁷ (AUTHOR), de Groot, D. J.⁸ (AUTHOR), de Groot, J. W. B.⁹ (AUTHOR), Haj Mohammad, N.¹ (AUTHOR), van Hillegersberg, R.¹ (AUTHOR), de Hingh, I. H.⁴ (AUTHOR), D'Hondt, M.¹⁰ (AUTHOR), Kerver, E. D.⁶ (AUTHOR)

Publikováno v: Trials. 4/29/2021, Vol. 22 Issue 1, p1-12. 12p. 1 Diagram, 2 Charts.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Short- and Long-term Outcomes of Surgery for Pancreatic Cancer in the Elderly

Autor: Henry, A.C., Schouten, T., Daamen, L., Walma, M., Noordzij, P., Besselink, M., Busch, O., Bonsing, B., Bosscha, K., van Dam, R., Festen, S., Koerkamp, B. Groot, van der Harst, E., de Hingh, I., Kazemier, G., Liem, M., de Meijer, V., Nieuwenhuijs, V., Roos, D., Schreinemakers, J., Stommel, M., Molenaar, Q., van Santvoort, H.

Publikováno v: In HPB 2022 24 Supplement 1:S391-S391

Survival benefit of resection of locally advanced pancreatic cancer following upfront FOLFIRINOX versus FOLFIRINOX only treatment: A propensity score-matched analysis

Autor: Brada, L., Daamen, L., Magermans, L., Walma, M., Latifi, D., van Dam, R., de Hingh, I., Liem, M., de Meijer, V., Patijn, G., Festen, S., Stommel, M., Bosscha, K., Polee, M., Nio, Y., Wessels, F., de Vries, J., van Lienden, K., Bruijnen, R., Busch, O., Koerkamp, B. Groot, van Eijck, C., Molenaar, Q., Wilmink, H., van Santvoort, H., Besselink, M.

Publikováno v: In Pancreatology July 2021 21 Supplement 1:S84-S84

Survival benefit of resection of locally advanced pancreatic cancer following upfront FOLFIRINOX versus FOLFIRINOX only treatment: a multicenter propensity score-matched analysis

Autor: Brada, L., Daamen, L., Magermans, L., Walma, M., Latifi, D., van Dam, R., de Hingh, I., Liem, M., de Meijer, V., Patijn, G., Festen, S., Stommel, M., Bosscha, K., Polée, M., Nio, C., Wessels, F., de Vries, J., van Lienden, K., Bruijnen, R., Busch, O., Koerkamp, B Groot, van Eijck, C., Molenaar, I., Wilmink, J., van Santvoort, H., Besselink, M.

Publikováno v: In HPB 2021 23 Supplement 2:S488-S488